NOCIL growth over the years

Compounded a year1 yr3 yr
Revenue−6.4%−6.9%
EBITDA−26.7%−26.4%
Net Income−45.9%−28.0%
EPS (adj.)−45.9%−28.0%
Total Assets+2.6%+4.4%
Total Equity+0.6%+4.5%
Free Cash Flow—−32.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NOCIL₹145.35

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹2,428 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue-6.4-6.9
EBITDA-26.7-26.4
Net Income-45.9-28.0
EPS (adj.)-45.9-28.0
Total Assets+2.6+4.4
Total Equity+0.6+4.5
Free Cash Flow—-32.6
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.